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Objectives. We assess whether it is feasible for robotic hysterectomy for endometrial cancer to be less expensive to society than
traditional laparoscopic hysterectomy or abdominal hysterectomy.Methods. We performed a retrospective cohort analysis of
patient characteristics, operative times, complications, and hospital charges from all (n = 234) endometrial cancer patients who
underwent hysterectomy in 2009 at our hospital. Per patient costs of each hysterectomy method were examined from the societal
perspective.SensitivityanalysisandMonteCarlosimulationwereperformedusingacost-minimizationmodel.Results.40(17.1%)
of hysterectomies for endometrial cancer were robotic, 91 (38.9%), were abdominal, and 103 (44.0%) were laparoscopic. 96.3% of
the variation in operative cost between patients was predicted by operative time (R = 0.963, P<0.01). Mean operative time for
robotic hysterectomy was signiﬁcantly longer than other methods (P<0.01). Abdominal hysterectomy was consistently the most
expensive while the traditional laparoscopic approach was consistently least expensive. The threshold in operative time that makes
robotic hysterectomy cost equivalent to the abdominal approach is within the range of our experience. Conclusion. It is feasible for
robotic hysterectomy to be less expensive than abdominal hysterectomy, but unlikely for robotic hysterectomy to be less expensive
than traditional laparoscopy.
1.Introduction
The burden of endometrial cancer worldwide is signiﬁcant,
particularly in developed nations battling concomitant epi-
demics of obesity [1]. In the USA and Europe, endometrial
cancer has become the most common gynecologic malig-
nancy and the fourth most common cancer site overall
[2]. The primary treatment for endometrial cancer is total
hysterectomy, bilateral salpingoopherectomy, and surgical
staging[3,4].IntheUSA,thetotalannualcostofthissurgery
approximates $250 million [5].
Until the advent of operative laparoscopy, the traditional
approach to the surgical management of endometrial cancer
was total abdominal hysterectomy (TAH). With the diﬀusion
of laparoscopic technology, there has been an increasing
trend towards minimally invasive methods [6]. Several large
randomized trials have demonstrated equivalent safety and
short-term clinical outcomes between TAH and laparoscopic
hysterectomy for endometrial cancer, including the Gyne-
cologic Oncology Group’s LAP-2 trial and the Australian
LACE trial [7, 8]. Furthermore, these trials have demon-
strated favorable quality of life outcomes for laparoscopic
hysterectomy compared to TAH in terms of shorter hospital
stays, less pain, and faster resumption of daily activities.
As a result of shorter hospitalization, for many patients,
total laparoscopic hysterectomy (TLH) is likely to be more
cost eﬀective to society than TAH in terms of incremental
costs per complication-free patient—however, this may not2 Obstetrics and Gynecology International
be the case in obese patients with BMI > 35 due to high
laparotomy conversion rates [9, 10]. Robot assisted total
laparoscopic hysterectomy (TRH) is an increasingly available
alternative that may confer an advantage in obese and other
complex patients by lowering the need for conversion. Suc-
cessful TRH for endometrial cancer in the setting of extreme
obesity (BMI 98) has been described in the literature with
patient discharge on postoperative day one [11]. Moreover,
several retrospective studies have demonstrated equivalent
safety and short-term clinical outcomes between TRH and
alternate methods [12–15].
Despite evidence demonstrating equivalent safety and
eﬃcacy between TAH, TLH, and TRH for correctly selected
patients, it remains uncertain how the robotic approach
comparestoothermethodsintermsofsocietalcosts.Robotic
surgery costs were found to be signiﬁcantly higher than
traditional laparoscopy for staging of endometrial cancer in
a small cohort of patients [16]. A modeling study based
on literature-review-derived parameter estimates veriﬁed
this ﬁnding, but also found that TRH is less expensive
than TAH when recovery time is taken account from the
societal perspective [17]. In this paper, we use a large cohort
from our institution to directly model the feasibility of
cost equivalence between TRH and alternate hysterectomy
methods from the societal perspective.
2.MaterialsandMethods
2.1. Data Collection. A l lh y s t e r e c t o m i e sp e r f o r m e df o r
endometrial cancer at the Brigham and Women’s Hospital
from January 1, 2009 to December 31, 2009 were obtained
from operating room (OR) case records. Only cases per-
formed by our four subspecialty-trained gynecologic oncol-
ogists were included. 234 women were identiﬁed who under-
went TAH, TLH, or TRH for endometrial cancer (vaginal
hysterectomy is not performed in patients with preoperative
diagnosis of endometrial cancer at our institution as this
mode of access precludes cytology and further staging). The
Brigham and Women’s Hospital is an academic tertiary care
center in Boston, Mass, USA. Our operating room is divided
into pods by specialty, so all supervising anesthesiologists,
circulating nurses, and scrub technicians were familiar with
gynecologic procedures. With the exception of four cases,
all surgeries included both residents and fellows as surgical
assistants. All patients were cared for postoperatively by a
single group of nurses on a gynecology women-only unit in
our institution.
WithInstitutionalReviewBoard(IRB)approvalfromthe
Brigham and Women’s Hospital, information was abstracted
from electronic medical records, and reviewed for each
patient. The information obtained from the charts included
the medical record number, date of birth, age, insurance
carrier, body mass index (BMI), parity, preoperative and
postoperative diagnoses, procedure performed, pathology
report, length of stay, surgeon, assistant type (attending, fel-
low, or resident), estimated blood loss (EBL), indication for
surgery, prior abdominal surgery, uterine weight, postoper-
ative complications, postoperative admission, intraoperative
complications, conversions, and “OR time.” It is important
to note that “OR time” was deﬁned as the total in-room to
out-of-room time instead of the commonly reported “skin-
to-skin” surgical time because the cost of utilizing an OR is
based on the total time the room is occupied. Therefore, in
addition, the length of time taken to perform the surgery,
“OR time,” includes time taken to intubate, position, and
otherwise prepare prior to skin incision, as well as the time
of patient recovery in the OR.
Intraoperative complications were deﬁned as bowel,
urological, or vascular injuries, or EBL > 1000mL [18].
Hospital accounting ledgers were used to obtain operative
and total encounter billing charges. Statistical descriptions
a n da n a l y s e sw e r ep e r f o r m e du s i n gS A Ss o f t w a r e( S A S
InstituteInc.,Cary,NC,USA;Version9.0).Associationswere
testedusingχ2 andFisherexacttestsforcategoricalvariables,
and with analysis of variance and two-sided Student’s t-tests
with Bonferroni correction for continuous variables where
appropriate. A multivariate linear and logistic regression
analysis was also performed for the variables under study
as they relate to the outcomes and costs as listed. A P value
<0.01 was considered signiﬁcant for all variables.
2.2. Cost Approximation. All costs were approximated from
the societal perspective. Using return to work following
surgery as the endpoint, societal costs include the direct
amount paid for surgery and associated hospitalization as
well as indirect lost labor production costs (foregone wages
from work absence while patients were recovering). The
amount that is reimbursed for a set of health services
varies considerably in the USA depending on a multitude
of individually negotiated agreements between public and
private payer organizations. Although the amount paid is
usually less than the standard hospital charges, hospital
charges provide an upper-bound estimate. In our cohort, 63
(26.9%) patients had health insurance through Medicare or
Medicaid with well-deﬁned reimbursement rates, 2 (0.9%)
patients were self-pay responsible for the full charge, and the
remaining 169 (72.2%) had private insurance with varying
negotiated reimbursements.
Hospital charges therefore overestimate the absolute
average amount paid. However, because our goal is to
determine whether it is at least feasible for TRH to be
less expensive than alternate hysterectomy methods, we use
hospital charges as a reliable upper-bound estimate because
i tp r e s e r v e sr e l a t i v ec o s td i ﬀerences between hysterectomy
methods in the most expensive scenario. Moreover, since
hospital charges are determined in an identical manner
for each patient in our cohort, using hospital charges
(rather than individually negotiated reimbursements) to
approximate payments maintains the internal validity of our
analysis.
The amount charged by our hospital for surgery was
obtained from hospital accounting ledgers and was deter-
mined based on direct costs (equipment cost and OR time)
and indirect costs in 5 categories (day surgery bed occu-
pancy, ambulatory procedure room occupancy if applicable,
recovery room bed occupancy, nursing staﬀ, and nonnursing
staﬀ).CostbasedonORtime(totaltimeuseoftheoperating
room from when the patient enters the OR to when theObstetrics and Gynecology International 3
patient leaves) is calculated according to a graduated scale
fee schedule that bills in 15-minute increments. This fee
schedule is based on a combination of labor, supplies, and
ﬁxed equipment for an operating room and is adjusted
every calendar year. Equipment cost is calculated based upon
standardized sets of equipment and supplies commonly used
by high-volume surgeons at our institution called “case
carts.” Any surgeon can request a standardized hysterectomy
“casecart”andsubsequentlyaddthecostofhisorherdesired
disposable tools. The cost of what the hospital pays for all
disposables and the depreciation cost of nondisposables are
itemized for each case. The cost of the equipment is then
multiplied by a graduated fee to create a patient charge. The
cost of robotic equipment is similarly amortized based on
depreciation cost and accounted for with a ﬂat fee for every
robot case.
Nonoperative charges for the associated hospitalization
are based on direct (labor, variable supplies including phar-
macy, laboratory, and blood bank, ﬁxed equipment) and
indirect costs (room and board based on cost of depreciation
per square foot of unit) related to the encounter. Surgeon
and anesthesia professional fees are based on the appropriate
Current Procedural Terminology (CPT) codes for the appro-
priate procedures (e.g., surgeon codes 58150 for TAH, or
58570 for TLH and TRH, etc.).
The additional indirect societal costs for each patient
were approximated as the cost of work “absenteeism” [17].
Average foregone wages from work absence, using median
wages reported by the National Bureau of Labor Statistics
and the published average return to work for patients
who undergo each hysterectomy method were calculated.
Work absences were valued using the median gender-speciﬁc
weekly salary for full-time workers ages 19 years and older,
accounting for the national unemployment rate in 2009.
Median weekly earnings were $657. Average USA work
absence per method of hysterectomy was obtained. Previ-
ously published mean return to work times are 38–41 days
after TAH [19, 20]. Return to work after TLH hysterectomy
is 19–24 days according to both our institutional data
and previously published data [21, 22]. Limited data exist
approximating return to work after TRH, though one study
suggests that return to normal activity may be faster for TRH
compared to TLH in a small cohort of patients [23]. Given
limited data and that no empirical reason to assume TRH
return to work would be fasterthan TLH in our cohort based
on number and size of incisions, we assumed equivalent
return to work times between TRH and TLH (19–24 days)
[21, 22].
2.3. Cost Analysis. To compare the costs of TAH, TLH,
and TRH, we created a decision tree model, as described
by the cost-analysis guidelines of the National Information
Center on Health Services Research and Health care Tech-
nology (NICHSR) (Figure 1)[ 24]. Given the assumption of
equivalent short-term “eﬀect” (i.e., successful removal of the
uterus) by each method, we conducted a cost-minimization
analysis rather than a cost-eﬀectiveness analysis. The cost
analysis was performed from the perspective of societal costs
as outlined above. Relevant clinical outcomes included in the
decision tree (need to convert to laparotomy and estimated
blood loss > 1000) were chosen based on a previously
published endometrial cancer hysterectomy cost decision
tree model [17]. Moreover, this model is also consistent
with a previously established institutional cost model at
our hospital, which found that the overwhelming majority
of variation in operative cost was driven by OR time and
that the primary time-extending variables were the need
to convert to laparotomy and intraoperative complication
rate [25]. We added the decision to perform lymph node
dissection as an additional variable for two reasons: (1) at
our institution lymph node, dissection is not performed
universally for all cases and (2) our institution bases OR
charges on 15-minute increments as detailed above, and
lymph node dissection added greater than 15 minutes to
the OR time in our experience. Based on the ﬁnding that
operative costs are primarily driven by OR time, our cost
model makes the additional assumption that the added cost
of doing a lymph node dissection, needing to convert to
laparotomy, or having an intraoperative complication such
as hemorrhage is equivalent to the cost of extended operative
time required.
All decision tree analysis was performed using TreeAge
Software (TreeAge Inc., Williamstown, Mass, USA). The
comparativecostsofTAH,TLH,andTRHwerecalculatedby
multiplying the costs associated with each clinical outcome
by the probabilities of the occurrence of that outcome and
then adding the nonoperative hospital charges and expected
indirect societal costs as outlined above. Probabilities and
costs were directly applied from our cohort database and
hospital accounting ledgers. Our model was tested deter-
ministically using one-way sensitivity analyses to assess the
eﬀects of varying OR time over the ranges experienced
by our cohorts, as well as probabilistically using Monte
Carlo simulation (Figure 3). To assess the uncertainty of our
estimates using Monte Carlo simulation, normal probability
distribution functions were substituted for each clinical out-
come variable in the decision tree based on cohort mean and
standarddeviation statistics. Givenno robotic conversionsin
ourcohort,previouslyreportedsummarystatisticswereused
to create probability distribution functions for Monte Carlo
simulation in this case [17].
3. Results
The characteristics of patients who underwent hysterectomy
by each method are summarized in Table 1.T h ea v e r a g ea g e
across all three cohorts was similar. Those who underwent
TRH tended to have the highest BMI (40.5, P<0.01),
while those who underwent TLH tended to have lowest
BMI (29.8, P<0.01). On average, patients who under-
went TLH were less surgically complex than patients who
underwent hysterectomy by other methods. These patients
tended to have the lowest incidence of prior laparotomy,
prior laparoscopy, and presence of adhesions. Moreover,
patients selected for TLH had the lowest average uterine
weight (134.4g). By contrast, patients selected for TAH
had the greatest average uterine weight (243.5g). Patients
who underwent TAH were also signiﬁcantly more likely to4 Obstetrics and Gynecology International
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Figure 1: Cost analysis decision tree. Decision model tree structure showing comparison of abdominal (TAH), laparoscopic (TLH), and
robotic(TRH)hysterectomymethods.Thesquaresdenotedecisionnodes,circlesdenoteprobabilitynodes,andtrianglesdenotetheterminal
nodes.Allprobabilitiesandoperatingroomtimesarebasedonourclinicalexperiencein2009assummarizedinTables1and2.Theoutcome
“nodes” in the model refer to lymph node dissection, and “hemorrhage” refers to EBL > 1000mL.
Table 1: Cohort characteristics. Number and % or mean and standard deviation (range).
Characteristics TAH
n = 73 (31.2%)
TLH
n = 118 (50.4%)
TRH
n = 43 (18.4%)
Age (years) 61.9, 9.2 (43–87) 59.9, 10.4 (34–91) 58.2, 7.57 (43–74)
BMI (kg/m2) 35.7, 10.1 (16.7–69.4) 29.8∗, 7.5 (19.7–59.2) 40.5∗, 11.0 (18.6–61.4)
Prior laparotomy 32 (46.4%) 35 (31.5%) 19 (46.3%)
Prior laparoscopy 13 (19.7%) 11 (10.5%) 10 (23.8%)
Adhesions 24 (32.9%) 17 (14.4%) 17 (39.5%)
Uterine weight (g) 243.5, 330.12 (25–2170) 134.4, 101.4 (34–704) 176.3, 153.34 (45.5–905)
Lymph Node Dissection (LND) 54 (74.0%)∗ 45 (38.5%) 16 (37.9%)
TAH: total abdominal hysterectomy, TLH: total laparoscopic hysterectomy, and TRH: total robotic hysterectomy; standard deviation reported where %d o e s
not occur. ∗P<0.01.
also undergo staging with lymph node dissection (74%,
P<0.01), compared to TLH (38.5%) and TRH (37.9%).
Multivariate regression demonstrated a small correlation
between lymph node dissection and hysterectomy type (R =
0.3, P<0.01), as well as uterine weight and hysterectomy
type (R = 0.18, P<0.01).
Perioperative outcomes and complications are summa-
rized by hysterectomy type in Table 2.O na v e r a g e ,T R H
required the longest use of the operating room (including
the skin-to-skin surgical time, setup, and turnover times),
totaling 252.6 minutes (P<0.01). Estimated blood loss
was signiﬁcantly lower for patients who underwent TLH and
TRH compared to patients who underwent TAH (P<0.01).
Compared to patients who underwent TAH, patients who
underwent TLH and TRH also stayed in the hospital for a
signiﬁcantly lower amount of time (P<0.01), consistent
with length of stays reported elsewhere in the literature
[12, 15, 26].Obstetrics and Gynecology International 5
Table 2: Perioperative outcomes and complications by hysterectomy type. Mean (SD) and range or number and (%).
TAH TLH TRH
OR time (min) 192.28 (181.08, 203.48) 186.80 (177.997, 195.61) 252.6∗‡(238.01, 267.19)
Estimated blood Loss (mL) 255.94 (215.74, 296.14) 105.23∗ (73.30, 137.07) 41.22∗ (−13.68, 96.12)
Length of Stay (days) 3.84 (3.46, 4.21) 1.44∗ (1.16, 1.72) 1.30∗ (0.83-1.77)
Conversions —6 ( 5 . 1 % ) 0
Organ injury 1 (1.37%) 1 (0.85%) 0
EBL ≥ 1000 1 (1.45%) 1 (0.91%) 0
Postoperative complications† 8 (11.0%) 8 (6.8%) 3 (7.0%)
TAH: total abdominal hysterectomy, TLH: total laparoscopic hysterectomy, and TRH: total robotic hysterectomy.
∗P<0.001 using one-way analysis of variance (TLH and TRH compared to TAH).
‡P<0.001 using one-way analysis of variance (TRH compared to TLH).
†Major (readmission, reoperation, ileus, hemorrhage) and minor complications (infections; chest, urinary, wound).
The rate of conversion to laparotomy was 5.1% for TLH
and 0% for TRH. Intraoperative complication rate was very
low with single incident of organ injury for TAH and TLH
(bladder injury in both cases) and a single incident of EBL
greater than 1000mL reported for TAH and TLH, and no
complicationsreportedforTRH.Postoperativecomplication
rates were similar across all three cohorts.
Cost approximations are summarized in Table 3,b a s e d
both on hospital accounting ledgers for each patient in
our database (total mean operative charge and total mean
encounter charge), as well as our cost model which addition-
ally accounts for variation in OR time and indirect societal
costs (expected societal cost). As described in Section 2,
these cost approximations are upper-bound estimates based
on standard hospital charges. Notably, analysis of variance
demonstrated that operative charges were most strongly
driven by operating room time (P<0.01) with an R-
value of 0.963. No other variable was signiﬁcantly associated
with operative charges, and the charges associated with
time use were 190-fold greater than charges associated with
equipment. It is therefore not surprising that the total mean
operative charge for TRH is the highest (P<0.01), given
that TRH also required the longest time use of the operating
room.
Mean encounter charge is highest for TAH (P<0.01)
as a result of longer lengths of stay in the hospital. The
expense of TAH increases relative to the minimally invasive
methods when return to work times are taken into account,
and foregone wages are added to the indirect societal costs
of the procedure. Ultimately, the expected total societal costs
are highest for TAH and lowest for TLH.
Each probability and outcome variable in our decision
treewereassignednormallydistributedprobabilityfunctions
and then randomly sampled in a probabilistic Monte Carlo
simulation in order to test the robustness of our expected
societal cost estimate. Figure 2 demonstrates the distribution
of societal costs estimates for each method of hysterectomy.
In all cases, the simulation resulted in estimates that were
closely clustered around our expected values.
We then individually conducted a one-way sensitivity
analysis on operating room time for each method of
hysterectomy. In each case, as operative room time was
Table 3: Total cost estimates.
TAH TLH TRH
Mean operative charge $33,756 $33,706 $44,698∗
Mean encounter charge $54,110∗ $39,367 $51,552∗
Expected societal cost $59,997 $41,339 $54,062
TAH: total abdominal hysterectomy, TLH: total laparoscopic hysterectomy,
and TRH: total robotic hysterectomy; ∗P<0.01. Uncertainty in the
expectedsocietalcostsisassessedusingaMonteCarlosimulation(Figure 2).
allowed to increase, the expected total societal cost increased
as well. Figure 3(a) demonstrates that, even for longer cases
in our cohort, the expected societal cost of TLH is less than
the expected costs of TRH or TAH. Figure 3(b) demonstrates
that, over the majority of our experience in operative time,
TRH is less expensive than the average expected societal
cost of TAH, but still more expensive than TLH. Moreover,
TRH becomes more expensive than TAH when the operating
room is utilized for more than approximately 300 minutes
(including the time of anesthesia induction and intubation,
equipment setup, etc.) Figure 3(c) demonstrates that the
fastest TAH cases in our experience approach the average
expected societal cost of TRH and are more expensive than
TLH by a wide margin. Figure 3(d) shows a Monte Carlo
simulation of the expected incremental cost diﬀerence to
society between TRH and TAH. In the majority of cases,
the estimated societal cost of TRH is less than the estimated
societal cost of TAH.
In all cases, TLH was consistently the least costly method
to society. In our experience, it is feasible for TRH to be less
expensive to society than TAH, but unlikely for TRH to be
less costly than TLH.
4. Discussion
There are many reasons why a surgeon may prefer a
particular method of hysterectomy for a given patient with
endometrial cancer. Conversely, there are many patients
for whom TAH, TLH, and TRH might all be appropriate.
Particularly in patients for whom more than one method
would be equivalently safe and eﬀective, it has become6 Obstetrics and Gynecology International
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Figure 2: Monte Carlo simulation of total expected societal costs. Expected total societal costs as determined by our model for each
hysterectomy method are reported in Table 3. Below are three corresponding Monte Carlo simulations demonstrating the expected
probability distribution of total societal costs, with total societal costs on x-axis and probability on y-axis.
increasingly important for healthcare providers to take
societal cost into account [27].
Elucidating the costs of procedures in the American
healthcaresystemisseldomstraightforwardgiventhediscor-
dance between the cost of providing a service, the amount a
patient is charged, and the amount a provider is reimbursed.
For that reason, the aim of our paper was not to determine
the absolute societal costs of hysterectomy for endometrial
cancer, but to assess the relative cost diﬀerences between
hysterectomymethods.Inparticular,wesoughttodetermine
whether it is at least feasible for TRH to be less expensive to
society than TLH or TAH.
To preserve consistency in the expected amount paid for
each patient, we used hospital charges as an upper-bound
estimate of our cost approximations. Other papers have con-
verted hospital charges to hospital costs using a multiplier of
0.5–0.7 as the “cost-to-charge ratio” [17, 28, 29]. Although
the absolute costs we describe here are higher than those
reported elsewhere in the literature, if we had applied this
adjustment, our expected societal costs would be similar toObstetrics and Gynecology International 7
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those previously published [5]. We did not feel that it
was necessary to apply this adjustment however as the
cost to charge relationship is often arbitrary and subject to
widespread regional variation within the USA. Moreover, by
usingchargestoprovideupper-boundsocietalcostestimates,
w ed e m o n s t r a t et h a ti ti sf e a s i b l ef o rT R Ht ob el e s sc o s t l y
to society than TAH even in the most expensive payment
scenario.
The OR utilization times we report in our study (in-
cluding setup, surgical time, and immediate recovery time)
may be longer than those experienced at institutions without
similar teaching missions. With rare exception, almost
all patients had both resident and fellow involvement as
assistants in their surgery. In addition, TRH is performed
selectively at our institution and is primarily reserved
for high-BMI patients, where longer operative times are
expected compared to patients with lower BMI.
Our institutional experience-based model oﬀers several
advantages. First, it likely reﬂects the experience of other
academic tertiary care centers that assess charges in a similar
manner. Second, while the other previously published cost-
minimization model essentially doubles the cost of cases
that are converted to laparotomy, we were able to assess the
cost of conversion and intraoperative complications more
directly by using the cost of extended time required from our
experience [17].
A primary limitation of our study design is that we
examine our cohorts retrospectively. As a result, there is an
inherent selection bias as patients appear to be selected for
certain hysterectomy methods based on surgical complexity.
For instance, patients selected for TAH are more likely to
have advanced disease requiring lymph node dissection and
were also more likely to have higher uterine weight and
adhesions from prior surgery. Ideally, the relative merits of
each method (including the expected societal costs) will be
assessed with a randomized control trial. To date, no such
trial exists.
The margin of beneﬁt to performing TRH in terms
of cost eﬃciency is likely to improve as surgeons become
increasingly familiar with this technology. Our data demon-
strates that our fastest TRH cases are substantially less
expensive than TAH. Since cost accrues for total OR time
utilization, there may also be opportunities to improve the
eﬃciency of setting up, docking, and disassembling the
robot.
Our study demonstrates that it at least feasible for TRH
to be less expensive than TAH. We also ﬁnd that TLH is
consistently the least costly method to society, a ﬁnding
supported by the previously published literature [17, 23].
Our institutional experience therefore suggests that it may be
best to perform TLH when possible to optimize societal cost
savings. However, if TLH is precluded by extreme obesity or
some other complexity, TRH is preferable from the societal
perspective to TAH.
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